Trials / Completed
CompletedNCT03030560
Longterm Postoperative Analgesia, Intravenous Lidocaine Infusion
Effect of Intravenous Lidocaine Infusion on Long Term Postoperative Pain After Spinal Fusion Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Abdelrady S Ibrahim, MD · Academic / Other
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Spinal fusion is a painful surgery, and control of postoperative pain is difficult. Several studies have indicated that appropriate pain treatment protocols reduce postoperative morbidity, improve the results of the surgery, and decrease hospital costs
Detailed description
Forty four patients were randomly allocated into two groups of equal size to receive either lidocaine infusion (Lidocaine group) or 0.9% sodium chloride infusion (Control group). Randomization: was performed using Lidocaine group and Control group registers, which was placed in sealed envelopes prior to study initiation and opened prior to anesthesia by a physician who prepared the intravenous solution and identified it with the patient number, according to the envelope drawn. The solution was handed to another physician, blind to the prepared solutions' content, who was responsible for the anesthesia. The solution volume was equal. The responsible investigator was remained blind to the chosen group until the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine | patients (n = 20) will receive a loading dose of lidocaine 2 mg ̸ kg slowly IV just before induction of anesthesia, then the lidocaine infusion started at a rate of 3 mg ̸ kg/h, and continued until the end of the operation. |
| DRUG | 0.9% Sodium-chloride | patients (n = 20) will receive an equal volume of 0.9% saline (both the loading and the infusion), the infusion will be initiated at the time of induction of anesthesia and continued until the end of the operation. |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-08-01
- Completion
- 2016-12-01
- First posted
- 2017-01-25
- Last updated
- 2017-11-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03030560. Inclusion in this directory is not an endorsement.